journal of men's health
Volume 7, Issue 1 , Pages 20-30 , March 2010

Attitudes, beliefs, and values regarding the sexual experience in men: development of the Sexual Experience Questionnaire

  • John P. Mulhall, MD

      Affiliations

    • Department of Urology, Weill Medical College of Cornell University & Memorial Sloan Kettering Cancer Center, New York, NY, USA
    • ,
  • Rosie King, MB, BS, FAChSHM

      Affiliations

    • Sydney Centre for Sex and Relationship Therapy, Sydney, NSW, Australia
    • ,
  • Dana J. Brimmer, PhD, MPH

      Affiliations

    • Abt Associates Inc., Cambridge, MA, USA
    • Current address: Centers for Disease Control and Prevention, Atlanta, GA, USA.
    • ,
  • James Harnett, PharmD, MS

      Affiliations

    • Pfizer Inc., USA
    • ,
  • Kyle Hvidsten, MPH

      Affiliations

    • Pfizer Inc., USA
    • ,
  • Sofia S. Kennedy, MPH

      Affiliations

    • Abt Associates Inc., Cambridge, MA, USA
    • ,
  • Prabashni Reddy, PharmD

      Affiliations

    • Abt Associates Inc., Cambridge, MA, USA
    • Current address: Partners Healthcare, Charlestown, MA, USA.
    • ,
  • Svetlana Denevich, PharmD

      Affiliations

    • Abt Bio-Pharma Solutions, Inc., Lexington, MA, USA
    • ,
  • Chris L. Pashos, PhD

      Affiliations

    • Abt Bio-Pharma Solutions, Inc., Lexington, MA, USA
    • Corresponding Author InformationCorresponding author.

Received 4 December 2008 ,Accepted 25 September 2009.

References 

  1. Sadovsky R, Mulhall JP. The potential value of erectile dysfunction inquiry and management. Int J Clin Pract. 2003;57:601–608
  2. National Institutes of Health. Kidney & Urologic Diseases: Erectile Dysfuntion. NIH Publication No.06-3923. Bethesda, MD: NKUDIC; 2005. Available at: http://kidney.niddk.nih.gov/kudiseases/pubs/impotence/index.htm. [Accessed August 29, 2009].
  3. Johannes CB, Araujo AB, Feldman HA, Derby CA, Kleinman KP, McKinlay JB. Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study. J Urol. 2000;163:460–463
  4. McKinlay JB. The worldwide prevalence and epidemiology of erectile dysfunction. Int J Impot Res. 2000;12(Suppl 4):S6–S11
  5. Guest JF, Das GR. Health-related quality of life in a UK-based population of men with erectile dysfunction. Pharmacoeconomics. 2002;20:109–117
  6. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: prevalence and predictors. JAMA. 1999;281:537–544
  7. Lowentritt BH, Sklar GN. The effect of erectile dysfunction on patient medication compliance. J Urol. 2004;171:231;[Abstract]
  8. Giuliano F, Pena BM, Mishra A, Smith MD. Efficacy results and quality-of-life measures in men receiving sildenafil citrate for the treatment of erectile dysfunction. Qual Life Res. 2001;10:359–369
  9. McLaughlin T, Harnett J, Burhani S, Scott B. Evaluation of erectile dysfunction therapy in patients previously nonadherent to long-term medications: a retrospective analysis of prescription claims. Am J Ther. 2005;12:605–611
  10. Muller MJ, Ruof J, Graf-Morgenstern M, Porst H, Benkert O. Quality of partnership in patients with erectile dysfunction after sildenafil treatment. Pharmacopsychiatry. 2001;34:91–95
  11. Paige NM, Hays RD, Litwin MS, Rajfer J, Shapiro MF. Improvement in emotional well-being and relationships of users of sildenafil. J Urol. 2001;166:1774–1778
  12. Salonia A, Rigatti P, Montorsi F. Sildenafil in erectile dysfunction: a critical review. Curr Med Res Opin. 2003;19:241–262
  13. de Boer BJ, Bots ML, Nijeholt AA, Moors JP, Verheij TJ. The prevalence of bother, acceptance, and need for help in men with erectile dysfunction. J Sex Med. 2005;2:445–450
  14. Rosen RC, Fisher WA, Eardley I, Niederberger C, Nadel A, Sand M. The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence of erectile dysfunction and related health concerns in the general population. Curr Med Res Opin. 2004;20:607–617
  15. Cappelleri JC, Bell SS, Althof SE, Siegel RL, Stecher VJ. Comparison between sildenafil-treated subjects with erectile dysfunction and control subjects on the Self-Esteem And Relationship questionnaire. J Sex Med. 2006;3:274–282
  16. Donatucci C, Eardley I, Buvat J, Gittelman M, Kell P, Segerson T, et al. Vardenafil improves erectile function in men with erectile dysfunction irrespective of disease severity and disease classification. J Sex Med. 2004;1:301–309
  17. Gheorghiu S, Godschalk M, Gentili A, Mulligan T. Quality of life in patients using self-administered intracavernous injections of prostaglandin E1 for erectile dysfunction. J Urol. 1996;156:80–81
  18. Willke RJ, Yen W, Parkerson GR, Linet OI, Erder MH, Glick HA. Quality of life effects of alprostadil therapy for erectile dysfunction: results of a trial in Europe and South Africa. Int J Impot Res. 1998;10:239–246
  19. Arrington R, Cofrancesco J, Wu AW. Questionnaires to measure sexual quality of life. Qual Life Res. 2004;13:1643–1658
  20. Strauss AL, Corbin J. Basics of Qualitative Research. Thousand Oaks, CA: Sage Publications; 1990;
  21. World Health Organization. Sexual Health: Working Definitions. Geneva: WHO; 2002. Available at: http://www.who.int/reproductive-health/gender/sexual_health.html. [Accessed July 13, 2006].
  22. Rosen RC, Catania J, Pollack L, Althof S, O’Leary M, Seftel AD. Male Sexual Health Questionnaire (MSHQ): scale development and psychometric validation. Urology. 2004;64:777–782
  23. Shabsigh R, Perelman MA, Laumann EO, Lockhart DC. Drivers and barriers to seeking treatment for erectile dysfunction: a comparison of six countries. BJU Int. 2004;94:1055–1065
  24. Holden CA, McLachlan RI, Pitts M, Cumming R, Wittert G, Agius PA, et al. Men in Australia Telephone Survey (MATeS): a national survey of the reproductive health and concerns of middle-aged and older Australian men. Lancet. 2005;366:218–224
  25. Braun M, Wassmer G, Klotz T, Reifenrath B, Mathers M, Engelmann U. Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey’. Int J Impot Res. 2000;12:305–311
  26. Blanker MH, Bosch JL, Groeneveld FP, Bohnen AM, Prins A, Thomas S, et al. Erectile and ejaculatory dysfunction in a community-based sample of men 50 to 78 years old: prevalence, concern, and relation to sexual activity. Urology. 2001;57:763–768
  27. Schou J, Holm NR, Meyhoff HH. Sexual function in patients with symptomatic benign prostatic hyperplasia. Scand J Urol Nephrol Suppl. 1996;179:119–122
  28. Souverein PC, Egberts AC, Sturkenboom MC, Meuleman EJ, Leufkens HG, Urquhart J. The Dutch cohort of sildenafil users: baseline characteristics. BJU Int. 2001;87:648–653
  29. Litwin MS, Nied RJ, Dhanani N. Health-related quality of life in men with erectile dysfunction. J Gen Intern Med. 1998;13:159–166

PII: S1875-6867(09)00366-2

doi: 10.1016/j.jomh.2009.09.035

journal of men's health
Volume 7, Issue 1 , Pages 20-30 , March 2010

Article Tools